A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
Fuente:
arXiv
Saved in:
| Main Authors: | Gu, Xuemin, Xu, Cong, Xu, Lei, Yu, Ying |
|---|---|
| Format: | Preprint |
| Published: |
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)
by: Long, James P., et al.
Published: (2025)
Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)
by: Zhang, Jiangshan, et al.
Published: (2025)
Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)
by: Kelter, Riko
Published: (2026)
A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)
by: Li, Yuhan, et al.
Published: (2024)
Optimal and Efficient Sample Size Re-estimation: A Dynamic Cost Framework
by: Jin, Rui, et al.
Published: (2025)
by: Jin, Rui, et al.
Published: (2025)
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)
by: Hall, Andrew, et al.
Published: (2025)
BayesPPDSurv: An R Package for Bayesian Sample Size Determination Using the Power and Normalized Power Prior for Time-To-Event Data
by: Shen, Yueqi, et al.
Published: (2024)
by: Shen, Yueqi, et al.
Published: (2024)
Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
by: Zhang, Jiangshan, et al.
Published: (2024)
by: Zhang, Jiangshan, et al.
Published: (2024)
Weighted Brier Score -- an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration
by: Zhu, Kehao, et al.
Published: (2024)
by: Zhu, Kehao, et al.
Published: (2024)
Bayesian Functional Analysis for Untargeted Metabolomics Data with Matching Uncertainty and Small Sample Sizes
by: Ma, Guoxuan, et al.
Published: (2023)
by: Ma, Guoxuan, et al.
Published: (2023)
Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
by: Stijven, Florian, et al.
Published: (2025)
by: Stijven, Florian, et al.
Published: (2025)
Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)
by: Zhang, Hong, et al.
Published: (2023)
CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)
by: Zhang, Fanni, et al.
Published: (2025)
Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)
by: Maity, Arnab Kumar, et al.
Published: (2024)
Sample Size Selection under an Infill Asymptotic Domain
by: Natoli, Cory W., et al.
Published: (2024)
by: Natoli, Cory W., et al.
Published: (2024)
Bayesian Power and Sample Size Calculations for Bayes Factors in the Binomial Setting
by: Kelter, Riko, et al.
Published: (2025)
by: Kelter, Riko, et al.
Published: (2025)
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)
by: Yang, Cheng-Han, et al.
Published: (2024)
Robust Power and Sample Size Calculations in Quasi-likelihood Models: Methods and Practice
by: Yuan, Shijie, et al.
Published: (2026)
by: Yuan, Shijie, et al.
Published: (2026)
Mediation Analysis in the Presence of Sample Selection Bias with an Application to Disparities in Liver Transplantation Listing
by: Khan, Zain, et al.
Published: (2025)
by: Khan, Zain, et al.
Published: (2025)
Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
by: Coent, Quentin Le, et al.
Published: (2025)
by: Coent, Quentin Le, et al.
Published: (2025)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)
by: Chen, Yuxuan, et al.
Published: (2026)
Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
by: Tanboga, Ibrahim Halil
Published: (2026)
by: Tanboga, Ibrahim Halil
Published: (2026)
A Corrected Score Function Framework for Modelling Circadian Gene Expression
by: Gorczyca, Michael, et al.
Published: (2024)
by: Gorczyca, Michael, et al.
Published: (2024)
Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
by: Gao, Yujing, et al.
Published: (2025)
by: Gao, Yujing, et al.
Published: (2025)
Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
by: Tu, Shengxin, et al.
Published: (2025)
by: Tu, Shengxin, et al.
Published: (2025)
Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)
by: Kelter, Riko
Published: (2026)
Bayesian Perspective for Orientation Determination in Cryo-EM with Application to Structural Heterogeneity Analysis
by: Xu, Sheng, et al.
Published: (2024)
by: Xu, Sheng, et al.
Published: (2024)
Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
by: Amevor, Robert, et al.
Published: (2026)
by: Amevor, Robert, et al.
Published: (2026)
Bias Mitigation in Matched Observational Studies with Continuous Treatments: Calipered Non-Bipartite Matching and Bias-Corrected Estimation and Inference
by: Frazier, Anthony, et al.
Published: (2024)
by: Frazier, Anthony, et al.
Published: (2024)
Adjustment for Unmeasured Spatial Confounding in Settings of Continuous Exposure Conditional on the Binary Exposure Status: Conditional Generalized Propensity Score-Based Spatial Matching
by: Kim, Honghyok, et al.
Published: (2022)
by: Kim, Honghyok, et al.
Published: (2022)
Risk-Calibrated Process Capability Approval with Finite Samples
by: Jiang, Fei, et al.
Published: (2026)
by: Jiang, Fei, et al.
Published: (2026)
Bayesian Network Propensity Score to Evaluate Treatment Effects in Observational Studies
by: Di Serio, Clelia, et al.
Published: (2025)
by: Di Serio, Clelia, et al.
Published: (2025)
Propensity Score Matching: Should We Use It in Designing Observational Studies?
by: Wan, Fei
Published: (2024)
by: Wan, Fei
Published: (2024)
Nonlinear Amplification of Finite-Sample Uncertainty in Capability-Based Decisions
by: Jiang, Fei, et al.
Published: (2026)
by: Jiang, Fei, et al.
Published: (2026)
Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)
by: Chassat, Perrine, et al.
Published: (2025)
Nonresponse Bias Analysis in Longitudinal Studies: A Comparative Review with an Application to the Early Childhood Longitudinal Study
by: Si, Yajuan, et al.
Published: (2022)
by: Si, Yajuan, et al.
Published: (2022)
Sample Size Calculations for the Development of Risk Prediction Models that Account for Performance Variability
by: Pavlou, Menelaos, et al.
Published: (2025)
by: Pavlou, Menelaos, et al.
Published: (2025)
Application of Propensity Score Models and Causal Estimators in Observational Studies under Model Misspecification
by: Das, Apu Chandra, et al.
Published: (2026)
by: Das, Apu Chandra, et al.
Published: (2026)
Estimation and Inference for Win Measures with Multiple Ordinal Endpoints Subject to Missingness
by: Liu, Yi, et al.
Published: (2026)
by: Liu, Yi, et al.
Published: (2026)
Propensity Score Methods for Local Test Score Equating: Stratification and Inverse Probability Weighting
by: Wallin, Gabriel, et al.
Published: (2024)
by: Wallin, Gabriel, et al.
Published: (2024)
Similar Items
-
Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025) -
Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025) -
Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026) -
A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024) -
Optimal and Efficient Sample Size Re-estimation: A Dynamic Cost Framework
by: Jin, Rui, et al.
Published: (2025)